Advertisement Biologics Modular initiates manufacturing facilities leasing program - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Biologics Modular initiates manufacturing facilities leasing program

Biologics Modular has signed an agreement with MEI Healthcare Capital to offer a leasing program for cleanrooms and drug manufacturing facilities.

The initiative is believed to help small and large companies to lease the facilities needed to produce FDA regulated material.

According to the company, this program will allow all innovation models to have an equal opportunity to access CGMP compliant manufacturing facilities at an affordable price.

Biologics Modular president and CEO Clark H Byrum said the current changes in the business model for drug manufacturing companies call for affordable quality facilities

"The new initiative is intended to allow research park companies to innovate more quickly without draining their capital," Byrum added.